ASX
LCT 0.125   Last updated 12.41 am
Fact sheet
The following fact sheets provide a summary of our current business and research pipeline.
Register for email updates
Register now to receive our newsletter and updates on LCT’s activities and progress.

Fact sheet

The following fact sheet provides a summary of our current business and research pipeline.

Products

Living Cell Technologies leads the world in cell transplant research. Our product pipeline consists of cell therapies developed from cells sourced from a unique herd of disease-free pigs bred from stock originally discovered in the remote sub-Antarctic Auckland Islands.

Our treatments are based on cell encapsulation and implantation for human therapeutics. Our lead product, NTCELL® is currently in Phase IIb clinical trials in New Zealand for the treatment of  Parkinson’s disease.

PRINT PAGE
Register for email updates
Register now to receive our newsletter and updates on LCT’s activities and progress.